Brandywine Global Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,815
| Closed | -$139K | – | 788 |
|
|
2020
Q1 | $139K | Sell |
11,815
-37
| -0.3% | -$435 | ﹤0.01% | 612 |
|
|
2019
Q4 | $275K | Sell |
11,852
-15
| -0.1% | -$348 | ﹤0.01% | 614 |
|
|
2019
Q3 | $220K | Sell |
11,867
-10,578
| -47% | -$196K | ﹤0.01% | 622 |
|
|
2019
Q2 | $418K | Buy |
22,445
+957
| +4% | +$17.8K | ﹤0.01% | 598 |
|
|
2019
Q1 | $526K | Sell |
21,488
-5,005
| -19% | -$123K | ﹤0.01% | 569 |
|
|
2018
Q4 | $688K | Sell |
26,493
-715
| -3% | -$18.6K | 0.01% | 555 |
|
|
2018
Q3 | $862K | Buy |
27,208
+28
| +0.1% | +$887 | 0.01% | 574 |
|
|
2018
Q2 | $1.06M | Sell |
27,180
-21,097
| -44% | -$820K | 0.01% | 581 |
|
|
2018
Q1 | $1.33M | Sell |
48,277
-21,508
| -31% | -$594K | 0.01% | 570 |
|
|
2017
Q4 | $1.26M | Sell |
69,785
-8,448
| -11% | -$153K | 0.01% | 572 |
|
|
2017
Q3 | $1.26M | Sell |
78,233
-2,637
| -3% | -$42.6K | 0.01% | 577 |
|
|
2017
Q2 | $1.12M | Sell |
80,870
-11,010
| -12% | -$153K | 0.01% | 600 |
|
|
2017
Q1 | $1.38M | Buy |
91,880
+51,429
| +127% | +$772K | 0.01% | 584 |
|
|
2016
Q4 | $530K | Sell |
40,451
-18,662
| -32% | -$245K | ﹤0.01% | 618 |
|
|
2016
Q3 | $1.02M | Sell |
59,113
-353
| -0.6% | -$6.09K | 0.01% | 587 |
|
|
2016
Q2 | $1.07M | Sell |
59,466
-14,619
| -20% | -$264K | 0.01% | 586 |
|
|
2016
Q1 | $1.41M | Sell |
74,085
-6,865
| -8% | -$130K | 0.01% | 560 |
|
|
2015
Q4 | $2.16M | Buy |
+80,950
| New | +$2.16M | 0.01% | 548 |
|